In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

German Law Misses Chance To Tackle Shortages By Tweaking Tenders

Executive Summary

Legislation passed by the German parliament will do little to address medicines shortages, because it will not tackle problems caused by exclusive tender contracts, the local off-patent industry believes.

You may also be interested in...



German Funds Deny Tenders Link To Shortages

Leaked political proposals to stop German insurance funds awarding tender contracts to just one supplier would not help to prevent drug shortages, insists the leading AOK group of funds.

German Medicines Safety Law Will ‘Do Nothing Against Shortages’

A provision in new German legislation that requires insurance funds to consider a variety of suppliers will do nothing to address drug shortages because it is not obligatory, local industry association Pro Generika believes.

German Fund Seeks Security By Choosing Several Suppliers

By sharing 80% of its tender contracts to multiple suppliers, German insurance fund Barmer is aiming to mitigate the risk of medicines shortages.

Related Content

Topics

UsernamePublicRestriction

Register

SC027449

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel